Endogenous cannabinoids linked to fetal brain damage imposed by maternal cannabis useMay 25, 2007A critical step in brain development is governed by endogenous cannabinoids, 'the brain's own marijuana'. Studies conducted at Swedish medical university Karolinska Institutet, with participation of scientists from Europe and the United States, are now published in Science and show that these endogenous molecules regulate how certain nerve cells recognize each other and form connections. The scientists believe that their findings will significantly advance our understanding of how cannabis smoking during pregnancy may damage the fetal brain. The formation of connections among nerve cells occurs during a relatively short period in the fetal brain. However, proper wiring of hundreds of millions of cells in our brains determine whether we can think, remember, move, or show emotions throughout our lives. For a nerve cell, recognizing its partners and establish connections with them is the key to survive and contribute to the control of brain functions. The process through which nerve cells recognize each other is guided by specific chemical signals whose availability instructs neurons to target or to ignore specific cells. Scientists have now identified that endogenous cannabinoids, molecules naturally produced by our brains and functionally similar to THC from cannabis, play unexpectedly significant roles in establishing how certain nerve cells connect to each other. These new and exciting results not only bolster out knowledge on the brain's normal development but may also take us closer to understanding if and when cannabis damages the fetal brain.
Endogenous cannabinoids use the same mechanism, engaging the CB1 cannabinoid receptor, as THC to exert their effects on nerve cells. Therefore, the finding that endogenous cannabinoids control the establishment of connections amongst certain nerve cells convinces the scientists that they have defined a key mechanism through which maternal cannabis use might impair fetal brain development and impose life-long cognitive, social, and motor deficits in affected offspring. "Besides identifying a fundamental mechanism in brain development, our findings may provide new perspectives to identifying the molecular changes in the brains of individuals prenatally affected by maternal cannabis abuse", says Dr. Tibor Harkany who has led the studies. "This is of social impact given the continuous growing use of marijuana, the most common illicit drug, in our society." Earlier studies have already found that children of marijuana-smoking mothers more frequently suffer from permanent cognitive deficits, concentration disorders, hyperactivity, and impaired social interactions than non-exposed children of the same age and social background. Karolinska Institutet | |||||||||||||||||||||
|
Related Cannabinoids News Articles Medicinal marijuana effective for neuropathic pain in HIV In a double-blind, placebo-controlled clinical trial to assess the impact of smoked medical cannabis, or marijuana, on the neuropathic pain associated with HIV, researchers at the University of California, San Diego School of Medicine found that reported pain relief was greater with cannabis than with a placebo. Milestone for cannabinoid MS study The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study. Schizophrenia linked to dysfunction in molecular brain pathway activated by marijuana Alterations in a molecular brain pathway activated by marijuana may contribute to the cognitive symptoms of schizophrenia, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Opioids and cannabinoids influence mobility of spermatozoids A PhD thesis from the University of the Basque Country has concluded that there are opioid and cannabinoid receptors in human sperm and that these influence the mobility of spermatozoid. Medicines derived from cannabis: a review of adverse events Researchers at the McGill University Health Centre (MUHC), McGill University and the University of British Columbia (UBC) determined that medical use of cannabinoids do not cause an increase in serious adverse events, but are associated with an increase in some non-serious adverse events. U of Minnesota researcher discovers the starting point of sun-induced skin cancer According to a new study from the University of Minnesota, the earliest event in the development of sun-induced skin cancer may have been identified. MIT study suggests caution on new anti-obesity drug in kids Anti-obesity drugs that work by blocking brain molecules similar to those in marijuana could also interfere with neural development in young children, according to a new study from MIT's Picower Institute for Learning and Memory. New brain cells implicated in machinery of cannabinoid signaling The brain cells called astrocytes, and not just neurons, are sensitive to the substances called cannabinoids-the active chemicals in marijuana. Researchers ID behavioral risk factors for head and neck cancers Researchers at the Johns Hopkins Kimmel Cancer Center have teased out two distinct sets of risk factors for head and neck cancers, suggesting that there are two completely different kinds of the disease. Curing addiction with cannabis medicines Smokers trying to quit in the future could do it with the help of cannabis based medicines, according to research from The University of Nottingham. More Cannabinoids News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||